p53-Independent ceramide formation in human glioma cells during gamma-radiation-induced apoptosis

Cell Death Differ. 2004 Aug;11(8):853-61. doi: 10.1038/sj.cdd.4401428.

Abstract

Although the p53 tumor-suppressor gene product plays a critical role in apoptotic cell death induced by DNA-damaging chemotherapeutic agents, human glioma cells with functional p53 were more resistant to gamma-radiation than those with mutant p53. U-87 MG cells with wild-type p53 were resistant to gamma-radiation. U87-W E6 cells that lost functional p53, by the expression of type 16 human papillomavirus E6 oncoprotein, became susceptible to radiation-induced apoptosis. The formation of ceramide by acid sphingomyelinase (A-SMase), but not by neutral sphingomyelinase, was associated with p53-independent apoptosis. SR33557 (2-isopropyl-1-(4-[3-N-methyl-N-(3,4-dimethoxybphenethyl)amino]propyloxy)benzene-sulfonyl) indolizine, an inhibitor of A-SMase, suppressed radiation-induced apoptotic cell death. In contrast, radiation-induced A-SMase activation was blocked in glioma cells with endogenous functional p53. The expression of acid ceramidase was induced by gamma-radiation, and was more evident in cells with functional p53. N-oleoylethanolamine, which is known to inhibit ceramidase activity, unexpectedly downregulated acid ceramidase and accelerated radiation-induced apoptosis in U87-W E6 cells. Moreover, cells with functional p53 could be sensitized to gamma-radiation by N-oleoylethanolamine, which suppressed radiation-induced acid ceramidase expression and then enhanced ceramide formation. Sensitization to gamma-radiation was also observed in U87-MG cells depleted of functional p53 by retroviral expression of small interfering RNA. These results indicate that ceramide may function as a mediator of p53-independent apoptosis in human glioma cells in response to gamma-radiation, and suggest that p53-dependent expression of acid ceramidase and blockage of A-SMase activation play pivotal roles in protection from gamma-radiation of cells with endogenous functional p53.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis / physiology*
  • Apoptosis / radiation effects
  • Ceramides / metabolism*
  • DNA-Binding Proteins / metabolism
  • Endocannabinoids
  • Enzyme Activation / drug effects
  • Enzyme Activation / physiology
  • Enzyme Inhibitors / pharmacology
  • Ethanolamines / pharmacology
  • Galactosylgalactosylglucosylceramidase / antagonists & inhibitors
  • Galactosylgalactosylglucosylceramidase / metabolism*
  • Gamma Rays
  • Glioblastoma / metabolism
  • Humans
  • Oleic Acids
  • Oncogene Proteins, Viral / metabolism
  • RNA, Small Interfering / metabolism
  • Sphingomyelin Phosphodiesterase / antagonists & inhibitors
  • Sphingomyelin Phosphodiesterase / metabolism*
  • Tumor Cells, Cultured
  • Tumor Suppressor Protein p53 / metabolism*

Substances

  • Ceramides
  • DNA-Binding Proteins
  • E6 protein, Human papillomavirus type 18
  • Endocannabinoids
  • Enzyme Inhibitors
  • Ethanolamines
  • Oleic Acids
  • Oncogene Proteins, Viral
  • RNA, Small Interfering
  • Tumor Suppressor Protein p53
  • N-oleoylethanolamine
  • Sphingomyelin Phosphodiesterase
  • Galactosylgalactosylglucosylceramidase